Related Experiment Videos
The day of contamination
Darcy L Kasner1, Michael E Spieth
1Marshfield Medical Research and Education Foundation, Nuclear Medicine Section, Marshfield Clinic, Marshfield, Wisconsin, USA.
Journal of Nuclear Medicine Technology
|March 8, 2003
Summary
Radioisotope urinary contamination is common, especially with (99m)Tc-Medronate bone scans. Recognizing distinct patterns in male and female patients helps avoid misinterpreting scans due to contamination.
Area of Science:
- Nuclear Medicine
- Radiopharmacy
- Medical Imaging
Background:
- Radioisotope administration for diagnostic imaging necessitates understanding excretion pathways.
- Urinary excretion is a primary route for many radiopharmaceuticals, including (99m)Tc-Medronate.
- Accurate interpretation of nuclear medicine scans depends on identifying and mitigating artifacts like contamination.
Observation:
- Three cases of suspected radioisotope urinary contamination were identified following (99m)Tc-Medronate administration.
- Two cases were confirmed urinary contamination, while one was a false-positive due to a visible urinary collection device.
- Distinct patterns of urinary contamination were noted between male and female patients.
Findings:
- Urinary contamination is a frequent occurrence in nuclear medicine procedures.
- Specific visual patterns associated with urinary contamination can aid in differentiation from true abnormalities.
- (99m)Tc-Medronate bone scans can exhibit characteristic contamination artifacts.
Implications:
- Awareness of urinary contamination patterns improves diagnostic accuracy in nuclear medicine.
- Proper identification of contamination prevents false-positive findings and unnecessary patient management.
- Further statistical data on radiopharmaceutical contamination is needed for comprehensive quality assurance.